Mt. Arlington, N.J., May 27, 2015 (BUSINESS WIRE) — PDS Life Sciences, a leading global provider of intuitive data management software and solutions for life sciences research, announced that Memorial Sloan Kettering Cancer Center, the world's oldest and largest private cancer center, has opted to use PDS’ Ascentos™ software suite to manage and analyze data that will be generated in its new GLP-compliant preclinical research laboratories.
Ascentos software includes toxicology, clinical pathology, reproductive toxicology and pathology modules that interface seamlessly to streamline data management from study setup to final reporting. Ascentos is a complete FDA SEND-ready preclinical solution because it captures data required by current and future versions of the CDISC SEND data standard.
"We’re honored to have Memorial Sloan Kettering as a client,” said Sayed Badrawi, CEO of PDS. “The institute is world-renowned for contributing to the discovery and development of oncology therapies, and its choice validates Ascentos as the new gold standard for ease of use, flexibility and rapid implementation."
PDS guarantees system validation in reasonable time periods and simplifies setup and usage training. After a rigorous, competitive assessment, the cancer center selected Ascentos because of its intuitive processes, rapid implementation and ability to automate fundamental laboratory workflows.
"We develop software that works like scientists think,” said Badrawi. “As innovative companies and research institutions continue to choose PDS’ Ascentos over the alternatives, it’s become clear that building software for the user — not just the data being compiled — is a key driver of value in the market."
To learn more about Ascentos and other PDS software solutions, including PDS’ groundbreaking FDA SEND data submission solutions, visit its website or schedule a demonstration at pdslifesciences.com.
For more than 30 years, PDS has provided intuitive data management software and solutions for life sciences research and development programs worldwide. Most of the world’s top 10 pharma companies rely on PDS software, as do industry-leading CROs, chemical companies, universities and regulatory agencies. The PDS software lineup is centered on Ascentos™, your integrated preclinical software solution, which is purpose-built to support toxicology, clinical pathology, reproductive toxicology and anatomic pathology. PDS also offers TranSEND™, your complete FDA submission management solution, as well as powerful bioinformatics analysis and other services. Learn more at pdslifesciences.com.